Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Jun Hong

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Journal of the American Heart Association|February 16, 2024
Prediction of In-Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane OxygenationJoo Hee Jeong, Hyungdon Kook, Seung Hun Lee, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial InfarctionSungA Bae, Jung-Joon Cha, Subin Lim, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 4, 2020
Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic functionHyungdon Kook, Jeong Hoon Yang, Jae Young Cho, et al.
Korean Circulation Journal|November 25, 2017
Bioresorbable Vascular Scaffold Korean Expert Panel ReportJung Min Ahn, Duk Woo Park, Sung Jin Hong, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trialEun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Lipids in Health and Disease|November 20, 2016
Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitusHyung Joon Joo, Sang-A Cho, Soon Jun Hong, et al.
The Journal of Invasive Cardiology|July 21, 2022
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Kyoung-Woo Seo, Hyoung-Mo Yang, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Clinical Therapeutics|September 14, 2025
Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSoon Jun Hong, Ju Hyeon Kim, Kwang Soo Cha, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|February 16, 2024
Prediction of In-Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane OxygenationJoo Hee Jeong, Hyungdon Kook, Seung Hun Lee, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial InfarctionSungA Bae, Jung-Joon Cha, Subin Lim, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 4, 2020
Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic functionHyungdon Kook, Jeong Hoon Yang, Jae Young Cho, et al.
Korean Circulation Journal|November 25, 2017
Bioresorbable Vascular Scaffold Korean Expert Panel ReportJung Min Ahn, Duk Woo Park, Sung Jin Hong, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trialEun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Lipids in Health and Disease|November 20, 2016
Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitusHyung Joon Joo, Sang-A Cho, Soon Jun Hong, et al.
The Journal of Invasive Cardiology|July 21, 2022
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Kyoung-Woo Seo, Hyoung-Mo Yang, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Clinical Therapeutics|September 14, 2025
Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSoon Jun Hong, Ju Hyeon Kim, Kwang Soo Cha, et al.
Pageof 22